$IZEA

IZEA Announces Q3 2025 Earnings Results Conference Call - IZEA Worldwide (NASDAQ:IZEA)

ORLANDO, Fla., Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- IZEA Worldwide, Inc. ( NASDAQ:IZEA ) , a leading influencer marketing company that makes Creator Economy solutions for marketers, announced today that its conference call to review and discuss its third quarter 2025 financial results will begin ...

Original reporting
Benzinga · Globe Newswire
Published Nov 3, 2025, 7:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 3, 2025, 8:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IZEA Announces Q3 2025 Earnings Results Conference Call - IZEA Worldwide (NASDAQ:IZEA) — source image
Decision brief

The 30-second read

$IZEABullishMed
01

Why it matters

The upcoming earnings call is a key event that could influence short-term stock performance based on financial disclosures.

02

Market read

The news is directly relevant to IZEA investors and traders, with moderate impact on short-term trading strategies.

03

What to watch

Broader market trends and macroeconomic factors could influence stock movement beyond earnings results.

Timing: Short-term (next 1-2 weeks) around earnings release date.

Background

IZEA Worldwide is a leading influencer marketing company providing Creator Economy solutions.

Company-level read

Ticker impact

$IZEABullishMedium confidence
Context

The news pertains directly to IZEA Worldwide's Q3 2025 earnings conference call, indicating company-specific developments.

Expected impact

Moderate upward movement expected if earnings meet or exceed expectations; potential decline if results disappoint.

Evidence & confidence

The sentiment score indicates mild bullishness, but the impact depends on actual earnings results, which are not yet disclosed. Technical indicators and current market conditions should be monitored for confirmation.

Market effects

Potential positive sentiment for influencer marketing and digital advertising sectors.

Primarily affecting US markets, given IZEA's US listing.

Limited; company-specific news with minimal immediate global impact.

Counterpoint

Disappointing earnings or guidance could lead to a sharp decline, offsetting any short-term gains.

Key entities

  • IZEA Worldwide, Inc.

    A publicly traded influencer marketing firm specializing in digital advertising solutions.

Related articles

$IZEAMedAI 8/10

IZEA (IZEA) Q2 2026 Earnings Call Transcript

IZEA reported Q2 2026 revenue of $5.8M, down 36% YoY, and a net loss of $0.7M, as it shifts to larger enterprise accounts. Managed services bookings fell 19% YoY, while SaaS revenue declined 32%. The company has $46.6M in cash and no long-term debt. Management highlighted new enterprise wins and an active M&A pipeline, but noted macroeconomic uncertainty.

$IZEAMed

IZEA Worldwide, Inc. (IZEA): Results of Operations and Financial Condition

IZEA Worldwide, Inc. (IZEA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991pressreleaseq220.htm EX-99.1 Document IZEA Reports Q2 2026 Revenue of $5.8 million, Advances Enterprise-Focused Growth Strategy Enterprise Relationships Remain Strong Amid Market Uncertainties ORLANDO, Fla. ( August 11, 2026 ) - IZEA Worldwide, Inc. (NASDAQ: I

$RBAHigh

Why This U.S. Auto Retail Stock is Barclays’ Top Pick Right Now

Barclays named RB Global Inc (RBA) its top U.S. auto retail pick, citing an attractive valuation at 12.7x EV/EBITDA, market share gains, and cyclical improvements in its Heavy Equipment & Transportation segment. RBA reported Q2 2026 revenue of $1.32B, beating estimates, with 11% gross transaction value growth. Barclays expects RBA to gain market share from Copart Inc (CPRT) in the salvage vehicle auction market.

$GHHighAI 8/10

Guardant ordered to pay $245m in DNA sequencing patent dispute

Guardant Health was ordered to pay $245.2m to TwinStrand Biosciences and the University of Washington for patent infringement. The ruling covers 11 products, including Guardant360 CDx, and includes damages, royalties, and interest. Guardant plans to appeal, while TwinStrand affirms its commitment to its intellectual property.

$KURAMed

Why is Kura Oncology stock surging today?

Kura Oncology's stock rose 11.6% in pre-market trading after CEO Troy Wilson bought 100,000 shares for $1.24 million, his second large purchase in a week. Analysts Citigroup and Jefferies reaffirmed positive ratings, citing strong commercial momentum for KOMZIFTI and Q2 earnings beat. The stock surpassed its 52-week high of $12.90.

$BEMed

Nancy Pelosi Made Millions On Nvidia Options. Now She’s Betting $3 Million On 1 AI Energy Stock

Paul Pelosi, spouse of House Speaker Nancy Pelosi, acquired 15,000 shares and 200 call options of Bloom Energy (BE) in July 2026, with a potential investment ranging from $3 million to $12 million. Bloom Energy reported Q2 2026 revenue of $1.065 billion, up 165.5% year-over-year, and raised full-year guidance to $3.9 billion to $4.2 billion. The stock closed at $204.02 on August 24, 2026, up 134.8% year-to-date. The Pelosi household also added to an existing Intel (INTC) position.